• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬皮病患者表皮中异常分化的角朊细胞表现出 CCN2 和 S100A9 的分泌增强。

Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.

机构信息

Centre for Rheumatology and Connective Tissue Diseases, Research Department of Inflammation, Division of Medicine, UCL-Medical School, London, UK.

Centre for Rheumatology and Connective Tissue Diseases, Research Department of Inflammation, Division of Medicine, UCL-Medical School, London, UK.

出版信息

J Invest Dermatol. 2014 Nov;134(11):2693-2702. doi: 10.1038/jid.2014.253. Epub 2014 Jun 16.

DOI:10.1038/jid.2014.253
PMID:24933320
Abstract

Skin involvement with dermal fibrosis is a hallmark of systemic sclerosis (SSc), and keratinocytes may be critical regulators of fibroblast function through secretion of chemo-attracting agents, as well as through growth factors and cytokines influencing the phenotype and proliferation rate of fibroblasts. Epithelial-fibroblast interactions have an important role in fibrosis in general. We have characterized the SSc epidermis and asked whether SSc-injured epidermal cells release factors capable of promoting fibrosis. Our results show that the SSc epidermis is hypertrophic, and has altered expression of terminal differentiation markers involucrin, loricrin, and filaggrin. Multiplex profiling revealed that SSc epidermal explants release increased levels of CCN2 and S100A9. CCN2 induction was found to spread into the upper papillary dermis, whereas S100A9 was shown to induce fibroblast proliferation and to enhance fibroblast CCN2 expression via Toll-like receptor 4. These data suggest that the SSc epidermis provides an important source of pro-fibrotic CCN2 and proinflammatory S100A9 in SSc skin, and therefore contributes to the fibrosis and inflammation seen in the disease.

摘要

皮肤纤维化是系统性硬化症(SSc)的一个标志,角质形成细胞可能通过分泌趋化因子,以及通过影响成纤维细胞表型和增殖率的生长因子和细胞因子,成为成纤维细胞功能的关键调节者。上皮-成纤维细胞相互作用在纤维化中起着重要作用。我们已经对 SSc 表皮进行了特征描述,并询问 SSc 损伤的表皮细胞是否释放能够促进纤维化的因子。我们的结果表明,SSc 表皮是肥大的,并且终末分化标志物 Involucrin、loricrin 和 filaggrin 的表达发生改变。多重分析显示,SSc 表皮外植体释放的 CCN2 和 S100A9 水平增加。发现 CCN2 的诱导作用会扩散到上部乳突真皮,而 S100A9 则通过 Toll 样受体 4 诱导成纤维细胞增殖,并增强成纤维细胞 CCN2 的表达。这些数据表明,SSc 表皮在 SSc 皮肤中提供了促纤维化的 CCN2 和促炎的 S100A9 的重要来源,因此有助于疾病中所见的纤维化和炎症。

相似文献

1
Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.系统性硬皮病患者表皮中异常分化的角朊细胞表现出 CCN2 和 S100A9 的分泌增强。
J Invest Dermatol. 2014 Nov;134(11):2693-2702. doi: 10.1038/jid.2014.253. Epub 2014 Jun 16.
2
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.上皮细胞通过白细胞介素-1α在系统性硬化症中促进成纤维细胞活化。
J Invest Dermatol. 2010 Sep;130(9):2191-200. doi: 10.1038/jid.2010.120. Epub 2010 May 6.
3
Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis.功能失调的角质形成细胞增加系统性硬化症的皮肤炎症:来自使用组织工程学硬皮病表皮的研究结果。
Arthritis Rheumatol. 2021 Jul;73(7):1311-1317. doi: 10.1002/art.41659. Epub 2021 May 18.
4
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.系统性硬化症内皮细胞通过诱导结缔组织生长因子(CCN2)/转化生长因子β依赖性间充质-间充质转化来募集并激活真皮成纤维细胞。
Arthritis Rheum. 2013 Jan;65(1):258-69. doi: 10.1002/art.37705.
5
IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.IL-22 使硬皮病患者皮肤成纤维细胞对 TNF 产生反应。
Ann Rheum Dis. 2016 Sep;75(9):1697-705. doi: 10.1136/annrheumdis-2015-207477. Epub 2015 Oct 9.
6
Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.硬皮病角质形成细胞可促进成纤维细胞活化,且不依赖于转化生长因子β 。
Rheumatology (Oxford). 2017 Nov 1;56(11):1970-1981. doi: 10.1093/rheumatology/kex280.
7
IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.IL-25 参与角质形成细胞驱动的真皮基质重塑,在系统性硬化症的表皮中减少。
Rheumatology (Oxford). 2022 Nov 2;61(11):4558-4569. doi: 10.1093/rheumatology/keac044.
8
Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis.地昔美仑,一种新型的口服黑色素皮质素 1 受体激动剂,在系统性硬化症的临床前模型中显示出疾病修饰作用。
Arthritis Res Ther. 2022 Sep 1;24(1):210. doi: 10.1186/s13075-022-02899-3.
9
The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.系统性硬化症成纤维细胞的纤维化表型随疾病持续时间和皮肤受累严重程度而变化:使用组织工程方法重建皮肤纤维化发展过程。
J Pathol. 2009 Mar;217(4):534-42. doi: 10.1002/path.2482.
10
Contribution of keratinocytes to dermal fibrosis.角质形成细胞对皮肤纤维化的贡献。
Curr Opin Rheumatol. 2022 Nov 1;34(6):337-342. doi: 10.1097/BOR.0000000000000895. Epub 2022 Aug 16.

引用本文的文献

1
Understanding the Role of Epithelial Cells in the Pathogenesis of Systemic Sclerosis.了解上皮细胞在系统性硬化症发病机制中的作用。
Cells. 2025 Jun 24;14(13):962. doi: 10.3390/cells14130962.
2
Serum Calprotectin as a Novel Biomarker of Disease Severity and Activity in Systemic Sclerosis Patients.血清钙卫蛋白作为系统性硬化症患者疾病严重程度和活动度的新型生物标志物。
Int J Mol Sci. 2025 May 1;26(9):4290. doi: 10.3390/ijms26094290.
3
Fibrosis: cross-organ biology and pathways to development of innovative drugs.纤维化:跨器官生物学与创新药物研发途径

本文引用的文献

1
Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities.弥漫性皮肤系统性硬皮病患者 S100A8 和 S100A9 的表达增加。与器官受累和免疫异常的相关性。
Clin Rheumatol. 2013 Oct;32(10):1501-10. doi: 10.1007/s10067-013-2305-4. Epub 2013 Jun 11.
2
S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.S100A9 通过晚期糖基化终产物受体介导的细胞外调节激酶 1/2、丝裂原活化蛋白激酶和核因子-κB 依赖性途径促进人肺成纤维细胞的激活。
Clin Exp Immunol. 2013 Sep;173(3):523-35. doi: 10.1111/cei.12139.
3
Nat Rev Drug Discov. 2025 Mar 18. doi: 10.1038/s41573-025-01158-9.
4
Regulation of involucrin and signalling pathway in scleroderma epidermal keratinocytes.硬皮病表皮角质形成细胞中兜甲蛋白及信号通路的调控
Postepy Dermatol Alergol. 2024 Dec;41(6):604-609. doi: 10.5114/ada.2024.144841. Epub 2024 Nov 8.
5
A pilot study of skin barrier function in patients with systemic sclerosis and primary Sjögren's syndrome.系统性硬化症和原发性干燥综合征患者皮肤屏障功能的初步研究。
J Rheum Dis. 2024 Oct 1;31(4):244-252. doi: 10.4078/jrd.2024.0032. Epub 2024 Jul 15.
6
An Assessment of Administration Route on MSC-sEV Therapeutic Efficacy.MSC-sEV 治疗功效的给药途径评估。
Biomolecules. 2024 May 24;14(6):622. doi: 10.3390/biom14060622.
7
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.基于生物信息学和二代测序数据分析的特发性肺纤维化潜在差异表达基因研究
Biomedicines. 2023 Nov 21;11(12):3109. doi: 10.3390/biomedicines11123109.
8
Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.全身博来霉素优于皮内次氯酸用于间质性肺病的研究。
Sci Rep. 2023 Nov 23;13(1):20577. doi: 10.1038/s41598-023-47083-y.
9
Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis.细胞转分化:系统性硬化症纤维化的关键机制。
Curr Rheumatol Rev. 2024;20(4):388-404. doi: 10.2174/0115733971261932231025045400.
10
Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis.自身抗体与系统性硬化症中角化细胞的结合及激活作用。
Cells. 2023 Oct 20;12(20):2490. doi: 10.3390/cells12202490.
Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.Toll 样受体 4 信号增强转化生长因子-β 反应:硬皮病纤维化维持和放大的新机制。
Am J Pathol. 2013 Jan;182(1):192-205. doi: 10.1016/j.ajpath.2012.09.007. Epub 2012 Nov 7.
4
Differential gene expression of MMP-1, TIMP-1 and HGF in clinically involved and uninvolved skin in South Africans with SSc.南非 SSc 患者受累和未受累皮肤中 MMP-1、TIMP-1 和 HGF 的差异基因表达。
Rheumatology (Oxford). 2012 Jun;51(6):1049-52. doi: 10.1093/rheumatology/ker367. Epub 2012 Jan 27.
5
The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example.慢性炎症在皮肤纤维化中的作用:以角质形成细胞中的成纤维细胞生长因子受体缺陷为例。
J Investig Dermatol Symp Proc. 2011 Dec;15(1):48-52. doi: 10.1038/jidsymp.2011.1.
6
Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis.人增生性瘢痕角质形成细胞 TIMP-1 的分泌增加可能有助于纤维化。
Burns. 2012 May;38(3):421-7. doi: 10.1016/j.burns.2011.09.001. Epub 2011 Oct 29.
7
The role of the epidermis and the mechanism of action of occlusive dressings in scarring.表皮的作用和封闭敷料在瘢痕形成中的作用机制。
Wound Repair Regen. 2011 Sep;19 Suppl 1(0 1):s16-21. doi: 10.1111/j.1524-475X.2011.00709.x.
8
Cell-extracellular matrix interactions in normal and diseased skin.细胞-细胞外基质在正常和病变皮肤中的相互作用。
Cold Spring Harb Perspect Biol. 2011 Apr 1;3(4):a005124. doi: 10.1101/cshperspect.a005124.
9
Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study.系统性硬皮病的组织病理学皮肤改变:一项临床病理学研究。
Arthritis Res Ther. 2011 Feb 28;13(1):R35. doi: 10.1186/ar3267.
10
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.粪便钙卫蛋白:系统性硬化症胃肠道疾病的生物标志物。
J Intern Med. 2011 Jul;270(1):50-7. doi: 10.1111/j.1365-2796.2010.02340.x. Epub 2011 Jan 9.